Citadel Advisors LLC reduced its stake in National HealthCare Co. (NYSEAMERICAN:NHC) by 13.3% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 13,541 shares of the company’s stock after selling 2,070 shares during the period. Citadel Advisors LLC owned approximately 0.09% of National HealthCare worth $848,000 at the end of the most recent quarter.
A number of other institutional investors and hedge funds also recently modified their holdings of the stock. Systematic Financial Management LP acquired a new position in National HealthCare in the 3rd quarter valued at about $1,168,000. SG Americas Securities LLC acquired a new position in National HealthCare in the 3rd quarter valued at about $155,000. Advisors Asset Management Inc. grew its position in National HealthCare by 9.6% in the 3rd quarter. Advisors Asset Management Inc. now owns 9,847 shares of the company’s stock valued at $616,000 after acquiring an additional 859 shares in the last quarter. Victory Capital Management Inc. grew its position in National HealthCare by 40.6% in the 3rd quarter. Victory Capital Management Inc. now owns 19,041 shares of the company’s stock valued at $1,191,000 after acquiring an additional 5,496 shares in the last quarter. Finally, Aperio Group LLC grew its position in National HealthCare by 7.8% in the 3rd quarter. Aperio Group LLC now owns 11,409 shares of the company’s stock valued at $714,000 after acquiring an additional 823 shares in the last quarter.
National HealthCare Co. (NYSEAMERICAN NHC) traded down $0.84 during midday trading on Monday, reaching $60.94. The company’s stock had a trading volume of 25,000 shares, compared to its average volume of 29,022. The firm has a market cap of $926.10, a P/E ratio of 19.04 and a beta of 0.39. National HealthCare Co. has a 52 week low of $57.73 and a 52 week high of $77.01.
National HealthCare (NYSEAMERICAN:NHC) last released its earnings results on Thursday, November 9th. The company reported $0.75 earnings per share for the quarter. National HealthCare had a return on equity of 6.60% and a net margin of 4.62%. The company had revenue of $241.99 million during the quarter.
The business also recently disclosed a quarterly dividend, which will be paid on Thursday, March 1st. Stockholders of record on Friday, December 29th will be given a dividend of $0.48 per share. This represents a $1.92 dividend on an annualized basis and a dividend yield of 3.15%. The ex-dividend date is Thursday, December 28th. National HealthCare’s dividend payout ratio is presently 60.00%.
Several research firms have weighed in on NHC. BidaskClub downgraded National HealthCare from a “sell” rating to a “strong sell” rating in a research report on Tuesday, November 7th. ValuEngine downgraded National HealthCare from a “hold” rating to a “sell” rating in a research report on Monday, October 2nd.
In other news, Director James Paul Abernathy sold 800 shares of the business’s stock in a transaction dated Wednesday, November 15th. The stock was sold at an average price of $64.00, for a total transaction of $51,200.00. Following the completion of the transaction, the director now directly owns 23,478 shares of the company’s stock, valued at $1,502,592. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, SVP Jeffrey Russell Smith sold 1,499 shares of the company’s stock in a transaction that occurred on Wednesday, November 29th. The shares were sold at an average price of $67.06, for a total value of $100,522.94. The disclosure for this sale can be found here.
ILLEGAL ACTIVITY NOTICE: “National HealthCare Co. (NHC) Shares Sold by Citadel Advisors LLC” was first reported by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are accessing this piece of content on another site, it was illegally stolen and reposted in violation of United States & international trademark & copyright legislation. The original version of this piece of content can be read at https://www.dispatchtribunal.com/2018/01/01/national-healthcare-co-nhc-holdings-trimmed-by-citadel-advisors-llc.html.
National HealthCare Profile
National HealthCare Corporation (NHC) is engaged in the operation of skilled nursing facilities, assisted living facilities, independent living facilities and homecare programs. The Company is engaged in the post-acute healthcare industry segment. Its business activities include providing sub-acute and post-acute skilled nursing care, intermediate nursing care, rehabilitative care, memory and Alzheimer’s care, senior living services, and home healthcare services.
Receive News & Ratings for National HealthCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National HealthCare and related companies with MarketBeat.com's FREE daily email newsletter.